Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 53
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Gen Virol ; 103(3)2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-35262477

RESUMEN

The family Adenoviridae includes non-enveloped viruses with linear dsDNA genomes of 25-48 kb and medium-sized icosahedral capsids. Adenoviruses have been discovered in vertebrates from fish to humans. The family is divided into six genera, each of which is more common in certain animal groups. The outcome of infection may vary from subclinical to lethal disease. This is a summary of the ICTV Report on the family Adenoviridae, which is available at ictv.global/report/adenoviridae.


Asunto(s)
Adenoviridae , Vertebrados , Animales , Peces , Genoma Viral , Virión , Replicación Viral
2.
Future Oncol ; 10(3): 377-84, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24559445

RESUMEN

BACKGROUND: We investigated whether the free ß-human chorionic gonadotropin (free ß-hCG) would provide additional information to that provided by total hCG alone and thus be useful in future epidemiological studies relating hCG to maternal breast cancer risk. MATERIALS & METHODS: Cases (n = 159) and controls (n = 286) were a subset of our previous study within the Northern Sweden Maternity Cohort on total hCG during primiparous pregnancy and breast cancer risk. RESULTS: The associations between total hCG (hazard ratio: 0.79; 95% CI: 0.49-1.27), free ß-hCG (hazard ratio: 0.85; 95% CI: 0.33-2.18) and maternal risk of breast cancer were very similar in all analyses and mutual adjustment for either one had minor effects on the risk estimates. CONCLUSION: In the absence of a reliable assay on intact hCG, total hCG alone can be used in epidemiological studies investigating hCG and breast cancer risk, as free ß-hCG does not appear to provide any additional information.


Asunto(s)
Neoplasias de la Mama/sangre , Gonadotropina Coriónica Humana de Subunidad beta/sangre , Hormonas Glicoproteicas de Subunidad alfa/sangre , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Persona de Mediana Edad , Embarazo , Riesgo
3.
Mar Drugs ; 12(2): 799-821, 2014 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-24477283

RESUMEN

Adenovirus infections in immunocompromised patients are associated with high mortality rates. Currently, there are no effective anti-adenoviral therapies available. It is well known that actinobacteria can produce secondary metabolites that are attractive in drug discovery due to their structural diversity and their evolved interaction with biomolecules. Here, we have established an extract library derived from actinobacteria isolated from Vestfjorden, Norway, and performed a screening campaign to discover anti-adenoviral compounds. One extract with anti-adenoviral activity was found to contain a diastereomeric 1:1 mixture of the butenolide secondary alcohols 1a and 1b. By further cultivation and analysis, we could isolate 1a and 1b in different diastereomeric ratio. In addition, three more anti-adenoviral butenolides 2, 3 and 4 with differences in their side-chains were isolated. In this study, the anti-adenoviral activity of these compounds was characterized and substantial differences in the cytotoxic potential between the butenolide analogs were observed. The most potent butenolide analog 3 displayed an EC50 value of 91 µM and no prominent cytotoxicity at 2 mM. Furthermore, we propose a biosynthetic pathway for these compounds based on their relative time of appearance and structure.


Asunto(s)
Actinobacteria/metabolismo , Infecciones por Adenoviridae/tratamiento farmacológico , Adenoviridae/efectos de los fármacos , Antivirales/farmacología , Infecciones por Adenoviridae/virología , Antivirales/química , Antivirales/aislamiento & purificación , Organismos Acuáticos/química , Relación Dosis-Respuesta a Droga , Descubrimiento de Drogas/métodos , Humanos , Noruega , Estereoisomerismo
4.
Mult Scler ; 19(12): 1587-91, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23549431

RESUMEN

BACKGROUND: The antibody reactivity against Epstein-Barr nuclear antigen-1 (EBNA-1), and 25-hydroxyvitamin D (25(OH)D) status have been associated with multiple sclerosis (MS) risk. Interaction between these two factors has been proposed. OBJECTIVES: The objective of this paper is to examine the association between antibody reactivity against EBNA-1 and five EBNA-1 domains, and the risk of MS, and to examine if these antibodies and 25(OH)D status interact regarding MS risk in prospectively collected blood samples. METHODS: Antibody reactivity and 25(OH)D levels were measured using ELISAs in n = 192 MS cases and n = 384 matched controls. The risk of MS was analysed using matched logistic regression. Interaction on the additive scale was assessed. RESULTS: The risk of MS increased across tertiles of antibody reactivity against EBNA-1, domain EBNA-1(402-502), and domain EBNA-1(385-420); p trends < 0.001. In young individuals (below median age at sampling, < 26.4 years), these associations were stronger, and 25(OH)D levels correlated inversely to antibody reactivity against EBNA-1 and the EBNA-1 domains. No statistical interaction was found. CONCLUSIONS: We confirm that increased antibody reactivity against EBNA-1 is a risk factor of MS. 25(OH)D status might influence the immune response towards Epstein-Barr virus in young subjects, and thereby modulate MS risk.


Asunto(s)
Anticuerpos Antivirales/análisis , Antígenos Nucleares del Virus de Epstein-Barr/sangre , Herpesvirus Humano 4/inmunología , Esclerosis Múltiple/inmunología , Esclerosis Múltiple/metabolismo , Vitamina D/análisis , Adulto , Anciano , Anticuerpos Antivirales/sangre , Estudios de Casos y Controles , Ensayo de Inmunoadsorción Enzimática , Infecciones por Virus de Epstein-Barr/inmunología , Femenino , Humanos , Inmunoglobulina G/análisis , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/sangre , Estudios Prospectivos , Riesgo , Suecia , Bancos de Tejidos , Vitamina D/clasificación
5.
Mult Scler ; 19(8): 1022-7, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23257617

RESUMEN

BACKGROUND: Smoking has been associated with an increased risk for multiple sclerosis, but no studies have measured levels of the nicotine metabolite cotinine in prospectively collected samples to assess exposure. OBJECTIVE: To investigate the effects of laboratory defined tobacco use on the risk for multiple sclerosis using prospectively collected biobank blood samples. METHODS: Levels of cotinine were measured in n=192 cases, and n=384 matched controls, using an immunoassay. The risk for multiple sclerosis was estimated using matched logistic regression. RESULTS: Elevated cotinine levels (≥10 ng/ml) were associated with a significantly increased risk for multiple sclerosis, (odds ratio, OR 1.5, 95% confidence interval, CI 1.0-2.1). This association was only present in young individuals (below median age at blood sampling, <26.4 years), (OR 2.2, 95% CI 1.3-3.8). CONCLUSIONS: This study confirms that smoking is a risk factor for multiple sclerosis. It has the advantage of using analyses of cotinine levels in samples that were collected several years before disease onset, thus excluding any risk for recall bias and minimising the risk for reversed causation. Our results also suggest that the smoking related immunological events that contribute to the development of multiple sclerosis occur early in life.


Asunto(s)
Cotinina/sangre , Esclerosis Múltiple/sangre , Esclerosis Múltiple/etiología , Fumar/efectos adversos , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Oportunidad Relativa , Factores de Riesgo , Fumar/sangre , Adulto Joven
6.
Mult Scler ; 19(8): 1046-51, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23334316

RESUMEN

BACKGROUND: Vitamin A is important for the immune system, and might suppress inflammatory activity in multiple sclerosis (MS). OBJECTIVES: We aimed to examine if vitamin A levels were associated with MS risk in samples collected prospectively and during gestation. METHODS: We measured Retinol Binding Protein (RBP--a surrogate marker for vitamin A) and high-sensitivity C-reactive protein (hs-CRP) levels, in (1) prospectively collected biobank blood samples from MS cases and controls, and (2) gestational samples where the offspring had later developed MS, and gestational control samples. The risk of MS was calculated using matched multivariable logistic regression adjusted for confounders. RESULTS: In prospective samples, RBP levels within the second quintile (vs. the first) were associated with a lower MS risk (OR = 0.38, 95% CI 0.19-0.74). No effect on MS risk in the offspring by gestational RBP levels was found. In young subjects hs-CRP levels ≥10 mg/l in prospective samples were associated with a lower MS risk (OR = 0.36, 95% CI 0.14-0.95). CONCLUSIONS: Our results suggest that sub-optimal vitamin A levels may be associated with MS risk. The association between hs-CRP levels and MS risk in young subjects may support the role of the hygiene hypothesis in MS aetiology.


Asunto(s)
Inflamación/metabolismo , Esclerosis Múltiple/sangre , Vitamina A/análisis , Adolescente , Adulto , Proteína C-Reactiva/análisis , Estudios de Casos y Controles , Femenino , Humanos , Persona de Mediana Edad , Embarazo , Proteínas de Unión al Retinol/análisis , Adulto Joven
7.
Antimicrob Agents Chemother ; 56(11): 5735-43, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22908173

RESUMEN

Herpes simplex viruses 1 and 2 (HSV-1 and HSV-2) are responsible for lifelong latent infections in humans, with periods of viral reactivation associated with recurring ulcerations in the orofacial and genital tracts. In immunosuppressed patients and neonates, HSV infections are associated with severe morbidity and, in some cases, even mortality. Today, acyclovir is the standard therapy for the management of HSV infections. However, the need for novel antiviral agents is apparent, since HSV isolates resistant to acyclovir therapy are frequently isolated in immunosuppressed patients. In this study, we assessed the anti-HSV activity of the antiadenoviral compounds 2-[2-(2-benzoylamino)-benzoylamino]benzoic acid (benzavir-1) and 2-[4,5-difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid (benzavir-2) on HSV-1 and HSV-2. Both compounds were active against both viruses. Importantly, benzavir-2 had potency similar to that of acyclovir against both HSV types, and it was active against clinical acyclovir-resistant HSV isolates.


Asunto(s)
Aciclovir/uso terapéutico , Antivirales/uso terapéutico , Benzamidas/uso terapéutico , Herpes Simple/tratamiento farmacológico , Herpesvirus Humano 1/efectos de los fármacos , Herpesvirus Humano 2/efectos de los fármacos , Aciclovir/farmacología , Adulto , Anciano de 80 o más Años , Animales , Antivirales/farmacología , Benzamidas/farmacología , Línea Celular , Chlorocebus aethiops , Farmacorresistencia Viral/efectos de los fármacos , Femenino , Herpes Simple/virología , Herpesvirus Humano 1/crecimiento & desarrollo , Herpesvirus Humano 1/aislamiento & purificación , Herpesvirus Humano 2/crecimiento & desarrollo , Herpesvirus Humano 2/aislamiento & purificación , Humanos , Masculino , Persona de Mediana Edad , Carga Viral/efectos de los fármacos , Ensayo de Placa Viral
8.
Cancer Causes Control ; 22(9): 1259-66, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21717196

RESUMEN

Few consistent etiological factors have been identified for primary brain tumors. Inverse associations to asthma and low levels of varicella-zoster virus, immunoglobulin (Ig) levels in prevalent cases have indicted a role for the immune system in the development of glioma. Because samples from prevalent cases of glioma could be influenced by treatments such as steroids and chemotherapy, we investigated pre-diagnostic samples from three large Scandinavian cohorts. To test the hypothesis that immune response levels to these viruses are associated etiologically with glioma risk, we investigated pre-diagnostic immunoglobulin levels for cytomegalovirus (CMV), varicella-zoster virus (VZV), adenovirus (Ad), and Epstein-Barr virus (EBV) including the nuclear antigen (EBNA1) using plasma samples from 197 cases of adult glioma and 394 controls collected from population-based cohorts in Sweden and Denmark. Low VZV IgG levels were marginally significantly more common in glioma cases than the controls (odds ratio (OR) = 0.68, 95% CI 0.41-1.13) for the fourth compared with the first quartile (p = 0.06 for trend). These results were more prominent when analyzing cases with blood sampling at least 2 years before diagnosis (OR = 0.63, 95% CI 0.37-1.08) (p = 0.03). No association with glioma risk was observed for CMV, EBV, and adenovirus.


Asunto(s)
Adenoviridae/inmunología , Anticuerpos Antivirales/inmunología , Glioma/inmunología , Glioma/virología , Inmunoglobulina G/inmunología , Infecciones por Adenoviridae/inmunología , Adulto , Anciano , Anticuerpos Antivirales/sangre , Antígenos Nucleares/inmunología , Neoplasias Encefálicas/etiología , Neoplasias Encefálicas/inmunología , Estudios de Casos y Controles , Estudios de Cohortes , Citomegalovirus/inmunología , Infecciones por Citomegalovirus/inmunología , Infecciones por Virus de Epstein-Barr/inmunología , Femenino , Herpes Zóster/inmunología , Herpesvirus Humano 3/inmunología , Herpesvirus Humano 4/inmunología , Humanos , Inmunoglobulina G/sangre , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Factores de Riesgo
9.
Antimicrob Agents Chemother ; 54(9): 3871-7, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20585112

RESUMEN

Adenovirus infections are widespread in society and are occasionally associated with severe, but rarely with life-threatening, disease in otherwise healthy individuals. In contrast, adenovirus infections present a real threat to immunocompromised individuals and can result in disseminated and fatal disease. The number of patients undergoing immunosuppressive therapy for solid organ or hematopoietic stem cell transplantation is steadily increasing, as is the number of AIDS patients, and this makes the problem of adenovirus infections even more urgent to solve. There is no formally approved treatment of adenovirus infections today, and existing antiviral agents evaluated for their antiadenoviral effect give inconsistent results. We have developed a whole cell-based assay for high-throughput screening of potential antiadenoviral compounds. The assay is unique in that it is based on a replication-competent adenovirus type 11p green fluorescent protein (GFP)-expressing vector (RCAd11pGFP). This allows measurement of fluorescence changes as a direct result of RCAd11pGFP genome expression. Using this assay, we have screened 9,800 commercially available small organic compounds. Initially, we observed approximately 400 compounds that inhibited adenovirus expression in vitro by > or = 80%, but only 24 were later confirmed as dose-dependent inhibitors of adenovirus. One compound in particular, 2-{[2-(benzoylamino)benzoyl]amino}-benzoic acid, turned out to be a potent inhibitor of adenovirus replication.


Asunto(s)
Adenoviridae/efectos de los fármacos , Adenoviridae/genética , Antivirales/farmacología , Ácido Benzoico/farmacología , Genes Reporteros/genética , Replicación Viral/genética , Antivirales/química , Ácido Benzoico/química , Línea Celular Tumoral , Citometría de Flujo , Humanos , Reacción en Cadena de la Polimerasa , Replicación Viral/efectos de los fármacos
10.
N Engl J Med ; 357(16): 1589-97, 2007 Oct 18.
Artículo en Inglés | MEDLINE | ID: mdl-17942872

RESUMEN

BACKGROUND: Screening for cervical cancer based on testing for human papillomavirus (HPV) increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia, but whether this gain represents overdiagnosis or protection against future high-grade cervical epithelial neoplasia or cervical cancer is unknown. METHODS: In a population-based screening program in Sweden, 12,527 women 32 to 38 years of age were randomly assigned at a 1:1 ratio to have an HPV test plus a Papanicolaou (Pap) test (intervention group) or a Pap test alone (control group). Women with a positive HPV test and a normal Pap test result were offered a second HPV test at least 1 year later, and those who were found to be persistently infected with the same high-risk type of HPV were then offered colposcopy with cervical biopsy. A similar number of double-blinded Pap smears and colposcopies with biopsy were performed in randomly selected women in the control group. Comprehensive registry data were used to follow the women for a mean of 4.1 years. The relative rates of grade 2 or 3 cervical intraepithelial neoplasia or cancer detected at enrollment and at subsequent screening examinations were calculated. RESULTS: At enrollment, the proportion of women in the intervention group who were found to have lesions of grade 2 or 3 cervical intraepithelial neoplasia or cancer was 51% greater (95% confidence interval [CI], 13 to 102) than the proportion of women in the control group who were found to have such lesions. At subsequent screening examinations, the proportion of women in the intervention group who were found to have grade 2 or 3 lesions or cancer was 42% less (95% CI, 4 to 64) and the proportion with grade 3 lesions or cancer was 47% less (95% CI, 2 to 71) than the proportions of control women who were found to have such lesions. Women with persistent HPV infection remained at high risk for grade 2 or 3 lesions or cancer after referral for colposcopy. CONCLUSIONS: The addition of an HPV test to the Pap test to screen women in their mid-30s for cervical cancer reduces the incidence of grade 2 or 3 cervical intraepithelial neoplasia or cancer detected by subsequent screening examinations. (ClinicalTrials.gov number, NCT00479375 [ClinicalTrials.gov].).


Asunto(s)
ADN Viral/análisis , Prueba de Papanicolaou , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/diagnóstico , Displasia del Cuello del Útero/diagnóstico , Neoplasias del Cuello Uterino/diagnóstico , Frotis Vaginal , Adulto , Colposcopía , Método Doble Ciego , Femenino , Humanos , Tamizaje Masivo , Papillomaviridae/genética , Reacción en Cadena de la Polimerasa , Sensibilidad y Especificidad , Neoplasias del Cuello Uterino/patología , Neoplasias del Cuello Uterino/prevención & control , Displasia del Cuello del Útero/patología , Displasia del Cuello del Útero/prevención & control
11.
Breast Cancer Res Treat ; 121(1): 169-75, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-19728079

RESUMEN

Previously, we reported that insulin-like growth factor (IGF)-I during early pregnancy is positively associated with maternal risk of breast cancer. To further explore this association, we designed a new study limited to women who donated a blood sample during their first pregnancy ending with childbirth. A case-control study was nested within the Northern Sweden Maternity Cohort in which repository since 1975, serum specimens remaining after early pregnancy screening for infectious diseases had been preserved. Study subjects were selected among women who donated a blood sample during the full-term pregnancy that led to the birth of their first child. Two hundred and forty-four women with invasive breast cancer were eligible. Two controls, matching the index case for age and date at blood donation were selected (n = 453). IGF-I was measured in serum samples on an Immulite 2000 analyzer. Conditional logistic regression was used to estimate odds ratios and 95% confidence intervals. A significant positive association of breast cancer with IGF-I was observed, with OR of 1.73 (95% CI: 1.14-2.63) for the top tertile, P < 0.009. Subgroup analyses did not indicate statistical heterogeneity of the association by ages at sampling and diagnosis or by lag time to cancer diagnosis, although somewhat stronger associations with risk were observed in women < or = age 25 at index pregnancy and for cases diagnosed within 15 years of blood donation. The results of the study add further evidence for an adverse effect of elevated IGF-I concentrations during early reproductive life on risk of breast cancer.


Asunto(s)
Neoplasias de la Mama/sangre , Factor I del Crecimiento Similar a la Insulina/análisis , Factor I del Crecimiento Similar a la Insulina/metabolismo , Embarazo/sangre , Adulto , Estudios de Casos y Controles , Femenino , Número de Embarazos , Humanos , Oportunidad Relativa , Factores de Riesgo
12.
Cancer Causes Control ; 21(5): 719-27, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20084544

RESUMEN

BACKGROUND: Little is known about correlates of first-trimester pregnancy hormones as in most studies maternal hormones have been measured later in gestation. We examined the associations of maternal characteristics and child sex with first-trimester maternal concentrations of four hormones implicated in breast cancer: human chorionic gonadotropin (hCG), alpha-fetoprotein (AFP), insulin-like growth factor (IGF)-I, and IGF-II. METHODS: About 338 serum samples donated to the Northern Sweden Maternity Cohort (NSMC), 1975-2001, during the first trimester of uncomplicated pregnancies, were analyzed for the hormones of interest as a part of a case-control study. The associations of maternal characteristics and child sex with hormone concentrations were investigated by correlation, general linear regression, and multivariate regression models. RESULTS: In the first trimester, greater maternal age was inversely correlated with IGF-I and IGF-II. In comparison with women carrying their first child, already parous women had higher IGF-I but lower hCG. Greater maternal weight and smoking were inversely correlated with hCG. No differences in hormone levels by child sex were observed. CONCLUSIONS: Our analyses indicated that potentially modifiable maternal characteristics (maternal weight and smoking) influence first-trimester pregnancy maternal hormone concentrations.


Asunto(s)
Gonadotropina Coriónica/sangre , Factor II del Crecimiento Similar a la Insulina/metabolismo , Factor I del Crecimiento Similar a la Insulina/metabolismo , Primer Trimestre del Embarazo/sangre , alfa-Fetoproteínas/metabolismo , Adulto , Peso Corporal , Estudios Transversales , Femenino , Humanos , Edad Materna , Paridad , Embarazo
13.
Int J Cancer ; 124(12): 2923-8, 2009 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-19330837

RESUMEN

According to the leading hypothesis on testicular cancer (TC) etiology exposure to a specific pattern of steroid hormones in utero, in particular, to high levels of estrogens and low levels of androgens is the major determinant of TC risk in the offspring. We performed a case-referent study nested within Finnish, Swedish and Icelandic maternity cohorts exploiting early pregnancy serum samples to evaluate the role of maternal endogenous steroid hormones with regard to the risk of TC. TC cases and referents were aged between 0 and 25 years. For each case-index mother pair, three or four matched referent-referent mother pairs were identified using national population registries. First trimester or early second trimester sera were retrieved from the index mothers of 73 TC cases and 286 matched referent mothers, and were tested for dehydroepiandrosterone sulfate (DHEAS), androstenedione, testosterone, estradiol, estrone, and sex hormone binding globulin (SHBG). Offspring of mothers with high DHEAS levels had a significantly decreased risk of TC (OR for highest vs. lowest DHEAS quartile, 0.18 (95% CI 0.06-0.58). In contrast, offspring of mothers with high androstenedione levels had an increased risk of TC (OR 4.1; 95% CI 1.2-12.0). High maternal total estradiol level also tended to be associated with an increased risk of TC in the offspring (OR 32; 95% CI 0.98-1,090). We report the first direct evidence that interplay of maternal steroid hormones in the early pregnancy is important in the etiology of TC in the offspring.


Asunto(s)
Hormonas Esteroides Gonadales/sangre , Efectos Tardíos de la Exposición Prenatal/epidemiología , Neoplasias Testiculares/epidemiología , Adolescente , Adulto , Androstenodiona/sangre , Estudios de Casos y Controles , Niño , Preescolar , Sulfato de Deshidroepiandrosterona/sangre , Estradiol/sangre , Estrona/sangre , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Embarazo , Medición de Riesgo , Factores de Riesgo , Globulina de Unión a Hormona Sexual/análisis , Testosterona/sangre , Adulto Joven
14.
Am J Epidemiol ; 169(4): 480-8, 2009 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-19074773

RESUMEN

The strong correlation between smoking and exposure to oncogenic human papillomaviruses (HPVs) has made it difficult to verify the independent role of smoking in cervical carcinogenesis. Thus, the authors evaluated this role. Five large Nordic serum banks containing samples from more than 1,000,000 subjects were linked with nationwide cancer registries (1973-2003). Serum samples were retrieved from 588 women who developed invasive cervical cancer and 2,861 matched controls. The samples were analyzed for cotinine (a biomarker of tobacco exposure) and antibodies to HPV types 16 and 18, herpes simplex virus type 2, and Chlamydia trachomatis. Smoking was associated with the risk of squamous cell carcinoma (SCC) among HPV16- and/or HPV18-seropositive heavy smokers (odds ratio=2.7, 95% confidence interval: 1.7, 4.3). A similar risk of SCC (odds ratio=3.2, 95% confidence interval: 2.6, 4.0) was found in heavy smokers after adjustment for HPV16/18 antibodies. The point estimates increased with increasing age at diagnosis and increasing cotinine level. This study confirms that smoking is an independent risk factor for cervical cancer/SCC in women infected with oncogenic HPVs. These findings emphasize the importance of cervical cancer prevention among women exposed to tobacco smoke.


Asunto(s)
Adenocarcinoma/etiología , Cotinina/sangre , Neoplasias de Células Escamosas/etiología , Fumar/efectos adversos , Infecciones Tumorales por Virus/complicaciones , Neoplasias del Cuello Uterino/etiología , Adenocarcinoma/sangre , Adenocarcinoma/epidemiología , Adulto , Anciano , Biomarcadores/sangre , Estudios de Casos y Controles , Chlamydia trachomatis/inmunología , Factores de Confusión Epidemiológicos , Europa (Continente)/epidemiología , Femenino , Herpesvirus Humano 2/inmunología , Papillomavirus Humano 16/inmunología , Papillomavirus Humano 18/inmunología , Humanos , Inmunoglobulina G/sangre , Modelos Logísticos , Persona de Mediana Edad , Neoplasias de Células Escamosas/sangre , Neoplasias de Células Escamosas/epidemiología , Oncogenes , Embarazo , Sistema de Registros , Factores de Riesgo , Fumar/sangre , Fumar/epidemiología , Neoplasias del Cuello Uterino/sangre , Neoplasias del Cuello Uterino/epidemiología
16.
Am J Epidemiol ; 168(11): 1284-91, 2008 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-18936438

RESUMEN

Pregnancy hormones are believed to be involved in the protection against breast cancer conferred by pregnancy. The authors explored the association of maternal breast cancer with human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP). In 2001, a case-control study was nested within the Northern Sweden Maternity Cohort, an ongoing study in which blood samples have been collected from first-trimester pregnant women since 1975. Cases (n = 210) and controls (n = 357) were matched for age, parity, and date of blood donation. Concentrations of hCG and AFP were measured by immunoassay. No overall significant association of breast cancer with either hCG or AFP was observed. However, women with hCG levels in the top tertile tended to be at lower risk of breast cancer than women with hCG levels in the lowest tertile in the whole study population and in subgroups of age at sampling, parity, and age at cancer diagnosis. A borderline-significant decrease in risk with high hCG levels was observed in women who developed breast cancer after the median lag time to cancer diagnosis (> or =14 years; odds ratio = 0.53, 95% confidence interval: 0.27, 1.03; P = 0.06). These findings, though very preliminary, are consistent with a possible long-term protective association of breast cancer risk with elevated levels of circulating hCG in the early stages of pregnancy.


Asunto(s)
Neoplasias de la Mama/sangre , Neoplasias de la Mama/epidemiología , Gonadotropina Coriónica/sangre , alfa-Fetoproteínas/metabolismo , Adulto , Biomarcadores/sangre , Estudios de Casos y Controles , Intervalos de Confianza , Femenino , Humanos , Inmunoensayo , Persona de Mediana Edad , Oportunidad Relativa , Embarazo , Estudios Prospectivos , Medición de Riesgo , Factores de Riesgo , Suecia/epidemiología , Adulto Joven
17.
APMIS ; 116(9): 816-22, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19024602

RESUMEN

During recent decades the incidence of testicular cancer (TC) has increased rapidly around the world. Associated exogenous etiological factors might therefore be identifiable. We performed a case-control study nested within Finnish, Swedish and Icelandic maternity cohorts exploiting early pregnancy serum samples to evaluate the role of congenital or neonatal infections with Epstein-Barr virus (EBV) and cytomegalovirus (CMV) as risk factors of TC in the offspring. For each case-index mother pair, three or four matched control-control mother pairs were identified using national population registries. First trimester sera were retrieved from the index mothers of 66 TC cases and 258 matched control mothers, and were tested for antibodies to EBV and CMV. High level of maternal EBV IgG antibodies was associated with significantly increased risk of TC in the offspring (odds ratio (OR), 2.50; 95% confidence interval (CI), 1.15, 5.40), especially with risk of non-seminoma TC (OR, 2.73; 950% CI, 1.25, 5.99) and non-seminoma TC diagnosed under 8 years of age (OR, 2.72; 95% CI, 1.05, 7.04). In contrast, offspring of CMV IgG-seropositive mothers had a decreased risk of TC diagnosed under 8 years of age (OR, 0.35; 95% CI, 0.14, 0.89). Our results suggest that EBV and CMV infections may be associated with TC.


Asunto(s)
Infecciones por Citomegalovirus/epidemiología , Citomegalovirus/crecimiento & desarrollo , Infecciones por Virus de Epstein-Barr/epidemiología , Herpesvirus Humano 4/crecimiento & desarrollo , Neoplasias Testiculares/virología , Adolescente , Adulto , Anticuerpos Antivirales/sangre , Estudios de Casos y Controles , Niño , Preescolar , Estudios de Cohortes , Infecciones por Citomegalovirus/sangre , Infecciones por Citomegalovirus/virología , Ensayo de Inmunoadsorción Enzimática , Infecciones por Virus de Epstein-Barr/sangre , Infecciones por Virus de Epstein-Barr/virología , Europa (Continente)/epidemiología , Femenino , Humanos , Inmunoglobulina G/sangre , Transmisión Vertical de Enfermedad Infecciosa , Masculino , Persona de Mediana Edad , Embarazo , Estudios Seroepidemiológicos , Neoplasias Testiculares/epidemiología , Adulto Joven
18.
Sci Rep ; 8(1): 1925, 2018 01 31.
Artículo en Inglés | MEDLINE | ID: mdl-29386590

RESUMEN

Rift Valley fever virus (RVFV) is a mosquito-borne hemorrhagic fever virus affecting both humans and animals with severe morbidity and mortality and is classified as a potential bioterror agent due to the possible aerosol transmission. At present there is no human vaccine or antiviral therapy available. Thus, there is a great need to develop new antivirals for treatment of RVFV infections. Benzavir-2 was previously identified as potent inhibitor of human adenovirus, herpes simplex virus type 1, and type 2. Here we assess the anti-RVFV activity of benzavir-2 together with four structural analogs and determine pre-clinical pharmacokinetic parameters of benzavir-2. In vitro, benzavir-2 efficiently inhibited RVFV infection, viral RNA production and production of progeny viruses. In vitro, benzavir-2 displayed satisfactory solubility, good permeability and metabolic stability. In mice, benzavir-2 displayed oral bioavailability with adequate maximum serum concentration. Oral administration of benzavir-2 formulated in peanut butter pellets gave high systemic exposure without any observed toxicity in mice. To summarize, our data demonstrated potent anti-RVFV activity of benzavir-2 in vitro together with a promising pre-clinical pharmacokinetic profile. This data support further exploration of the antiviral activity of benzavir-2 in in vivo efficacy models that may lead to further drug development for human use.


Asunto(s)
Antivirales/farmacología , Antivirales/farmacocinética , Benzoatos/farmacología , Benzoatos/farmacocinética , Virus de la Fiebre del Valle del Rift/fisiología , Células A549 , Administración Oral , Animales , Antivirales/administración & dosificación , Antivirales/química , Benzoatos/administración & dosificación , Benzoatos/química , Disponibilidad Biológica , Femenino , Humanos , Ratones Endogámicos BALB C , ARN Viral/genética , Fiebre del Valle del Rift/tratamiento farmacológico , Fiebre del Valle del Rift/prevención & control , Fiebre del Valle del Rift/virología , Virus de la Fiebre del Valle del Rift/efectos de los fármacos
20.
J Inflamm (Lond) ; 14: 19, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28919840

RESUMEN

BACKGROUND: Sepsis is a life-threatening condition and obesity is related to the clinical outcome. The underlying reasons are incompletely understood, but the adipocyte derived hormones leptin and adiponectin may be involved. METHODS: Patients aged 18 years or more with documented first time sepsis events were included in a nested case-referent study if they had participated in previous health surveys. Two matched referents free of known sepsis were identified. Circulating levels of leptin and adiponectin were determined in stored plasma, and their impact on a future sepsis event and its outcome was evaluated. RESULTS: We identified 152 patients (62% women) with a sepsis event and a previous participation in a health survey. Eighty-three % had also blood samples from the acute event. Hyperleptinemia at health survey associated with a future sepsis event (OR 1.77, 95% CI 1.04-3.00) and with hospital death. After adjustment for BMI leptin remained associated with sepsis in men, but not in women. High levels in the acute phase associated with increased risk for in hospital death in women (OR 4.18, 95% CI 1.17-15.00), while being protective in men (OR 0.05, 95% CI 0.01-0.48). Furthermore, leptin increased more from baseline to the acute phase in men than in women. Adiponectin did not predict sepsis and did not relate to outcome. CONCLUSIONS: Hyperleptinemia independently predicted the development of sepsis and an unfavourable outcome in men, and inertia in the acute response related to worse outcome.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA